Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

Gilead Sciences

Gilead and Verily team up to map inflammatory diseases

Computational analysis could provide deeper understanding of disease

Sanofi reception

Sanofi’s latecomer PD-1 gets date for FDA verdict

While Keytruda extends its lead, Sanofi makes a late bid to enter PD-1 space

- PMLiVE

Elizabeth Egan joins Havas Lynx

She joins as the agency’s new managing director

ProPharma selects new CEO and president

Dawn Sherman takes up the roles effective 14 May

- PMLiVE

Disruptive technologies set to stabilise soaring drug prices

AI and blockchain could accelerate the drug development process, says report

- PMLiVE

Keytruda gains NICE clearance in first line bladder cancer

MSD extends advantage in immunotherapy with Cancer Drugs Fund clearance

What’s the secret to leadership in joint working?

Dovetail Director Claire Munro on effective leadership strategies that drive results in joint working between pharma and clinical groups.

Dovetail

- PMLiVE

CHMP backs first-line use for AZ’s Tagrisso in lung cancer

AstraZeneca, Roche and Gilead among companies one step closer to approval

- PMLiVE

Morning brief: Allergan’s migraine results, Biktarvy approved in Europe and more

A rapid run-down of news in pharma, biotech and healthcare

- PMLiVE

Allergan’s oral migraine drug closer to US filing

New data keeps Allergan ahead of rival Biohaven

Lucid Group – Hanging tough in support of Wycombe Homeless Connection

This Saturday, 19 brave Lucidians took to the fields of Henley to conquer the first of Tough Mudder’s 2018 obstacle course events. The Tough Mudder course features 13 obstacles over...

Lucid Group Communications Limited

- PMLiVE

Sandoz targets digital therapeutics

Partners with Pear Therapeutics to launch FDA-approved apps

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links